About CueZen
CueZen is a company based in Seattle (United States) founded in 2021 by Aloysius Lim, Ankur Teredesai, and Sunil Shinde. CueZen has raised $5.2 million across 1 funding round from investors including Point72 Ventures, Pack Ventures and Fortson Venture Capital. CueZen offers products and services including Personalization Engine and Health Coaching Platform. CueZen operates in a competitive market with competitors including Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Shengshi Technology, among others.
- Headquarter Seattle, United States
- Founders Aloysius Lim, Ankur Teredesai, Sunil Shinde
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cuezen Labs Private Limited
- Date of Incorporation 07 Oct, 2024
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.2 M (USD)
in 1 rounds
-
Latest Funding Round
$5.2 M (USD), Seed
Apr 15, 2025
-
Investors
Point72 Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CueZen
CueZen offers a comprehensive portfolio of products and services, including Personalization Engine and Health Coaching Platform.
Engine for delivering hyper-personalized health coaching and nudges
Platform integrating AI for wellness and chronic care management
Funding Insights of CueZen
CueZen has successfully raised a total of $5.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.2 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $5.2M
-
First Round
First Round
(15 Apr 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Seed - CueZen | Valuation | Point72 Ventures |
Investors in CueZen
CueZen has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Point72 Ventures, Pack Ventures and Fortson Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies
|
Founded Year | Domain | Location | |
|
Pack Ventures is involved in unspecified business activities.
|
Founded Year | Domain | Location | |
|
Seed stage investments are offered by Fortson Venture Capital.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CueZen
Financial Statements - CueZen
Cuezen Comparisons
Competitors of CueZen
CueZen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Shengshi Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform for human genome study is provided for precision medicine.
|
|
| domain | founded_year | HQ Location |
AI-enabled platform for microbiome data generation and analysis is developed.
|
|
| domain | founded_year | HQ Location |
AI-enabled molecular imaging and theranostics for disease diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Evidence-based drug information is provided to healthcare providers online.
|
|
| domain | founded_year | HQ Location |
AI and cloud-based precision diagnosis tools for healthcare are developed.
|
|
| domain | founded_year | HQ Location |
Storage, management and analysis of omic data for health applications
|
Frequently Asked Questions about CueZen
CueZen was founded in 2021 and raised its 1st funding round 4 years after it was founded.
CueZen is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Ankur Teredesai is the current CEO of CueZen. They have also founded this company.
CueZen is a funded company, having raised a total of $5.2M across 1 funding round to date. The company's 1st funding round was a Seed of $5.2M, raised on Apr 15, 2025.
Provider of AI powered personalization engine for health behavior change. The engine facilitates the creation of personalized health coaching agents, enabling seamless auto updates for digital twins and maintaining data security within the clients cloud. The platform integrates with various health trackers and leverages existing AI and health investments. It is designed for scalability and supports government grade security and compliance standards. The solution aims to enhance health outcomes through hyper personalized nudges, enhancing enrollment, engagement, and adherence to health programs. It offers end to end capabilities for enterprises seeking to enhance personalized health engagement.
CueZen's top competitors include Omega Therapeutics, BAMF Health and dātma.
CueZen offers Personalization Engine and Health Coaching Platform.
CueZen has 3 investors. Key investors include Point72 Ventures, Pack Ventures, and Fortson Venture Capital.